Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Eur J Paediatr Dent ; 25(2): 149-154, 2024 06 03.
Artículo en Inglés | MEDLINE | ID: mdl-38778771

RESUMEN

BACKGROUND: Orofacial trauma (OFT) occurs frequently in children and requires thorough evaluation not only by paediatric dentists but also by all specialists involved in emergency services, particularly in cases involving children under 3 years of age, given their inability to directly participate in clinical-anamnestic evaluations. Addressing early childhood orofacial trauma resulting from maltreatment, this study explores the key role played by various healthcare professionals, including paediatric dentists, general dentists, maxillofacial surgeons, dental hygienists, and paediatricians, in the optimal management of these cases. In the event of trauma due to suspected or confirmed mistreatment, it is essential that all healthcare workers involved have precise knowledge of the appropriate course of action from both a clinical and legal point of view, guaranteeing maximum protection for the young patient. This is particularly significant as cases of mistreatment with apparently minor consequences can degenerate into situations of irreparable severity. The latest guidelines from the International Association of Dental Traumatology (IADT) in 2020 continue to emphasise the potential correlation between OFT and cases of abuse or violence. Recent recommendations in the literature highlight the importance of facilitating mandatory reporting of incidents to relevant authorities and improving information sharing between dental healthcare professionals and child welfare services. A new flow diagram, called Paediatric Orofacial Trauma Alert (P.O.T.A.), has been proposed at the University of Verona. This tool is specifically designed to assist specialists dealing with early childhood orofacial trauma cases by assisting them in identifying potential cases of maltreatment. In this innovative approach, the collaborative efforts of general dentists, paediatric dentists, maxillofacial surgeons, dental hygienists and paediatricians play a vital role in cases of abuse. In addition to restoring the oral health of young patients, these professionals can activate a vast network of contacts, ensuring not only optimal oral health care but also providing comprehensive support to victims. The objective is to safeguard not only the physical but also the psychological well-being of these vulnerable subjects.


Asunto(s)
Maltrato a los Niños , Humanos , Preescolar , Maltrato a los Niños/diagnóstico , Traumatismos Faciales/terapia , Italia , Grupo de Atención al Paciente , Lactante
2.
J Dermatolog Treat ; 33(1): 401-407, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-32349568

RESUMEN

BACKGROUND: Cyclosporine A (CsA) is one of the systemic therapeutic options for moderate-to-severe psoriasis, based on its efficacy and rapidity of action. The current study investigated the response to CsA in patients with moderate-to-severe plaque psoriasis. MATERIALS AND METHODS: TRANSITION was an observational, cross-sectional, multicentre study which evaluated the proportion of partial- and suboptimal-responders among patients with moderate-to-severe plaque psoriasis treated with continuous CsA for ≥12 weeks. Patients demonstrating a Psoriasis Area and Severity Index (PASI) response of ≥90, ≥75 and <90, ≥50 and <75 and <50 were defined as responders, suboptimal-responders, partial-responders, and non-responders, respectively. RESULTS: A total of 196 patients (mean age, 46.6 years; 62.8% males) from 14 sites in Italy were evaluated. At the study visit, the mean (SD) PASI score was 4.2(5.5) compared with 15.3(7.1) prior to the last CsA cycle. For response categories, 39.8%, 22.4%, 16.8%, and 20.9% of patients were responders, suboptimal-responders, partial-responders, and non-responders to CsA treatment. Overall, 28.6% of patients permanently discontinued treatment with CsA (lack of efficacy [10.2%], poor tolerability and voluntary discontinuation [3.6% each], and other [11.7%]). CONCLUSION: Patients were only partially satisfied with CsA treatment, reporting measurable impact on quality of life. Only 40% patients showed a satisfactory response to CsA.


Asunto(s)
Ciclosporina , Psoriasis , Estudios Transversales , Ciclosporina/uso terapéutico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Psoriasis/tratamiento farmacológico , Calidad de Vida , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
3.
Oncogene ; 25(39): 5391-404, 2006 Aug 31.
Artículo en Inglés | MEDLINE | ID: mdl-16607279

RESUMEN

Mutational activation of ras genes is required for the onset and maintenance of different malignancies. Here we show, using a combination of molecular physiology, nutritional perturbations and transcriptional profiling, that full penetrance of phenotypes related to oncogenic Ras activation, including the shift of carbon metabolism towards fermentation and upregulation of key cell cycle regulators, is dependent upon glucose availability. These responses are induced by Ras activation, being specifically reverted by downregulation of the Ras pathway obtained through the expression of a dominant-negative Ras-specific guanine nucleotide exchange protein. Our data allow to link directly to ras activation the alteration in energy metabolism of cancer cells, their fragility towards glucose shortage and ensuing apoptotic death.


Asunto(s)
Apoptosis/fisiología , Transformación Celular Neoplásica , Fibroblastos/fisiología , Proteínas ras/metabolismo , Animales , Ciclo Celular , Muerte Celular , Células Cultivadas , Activación Enzimática , Glucosa/metabolismo , Cinética , Ácido Láctico/metabolismo , Ratones
4.
Biochem Soc Trans ; 33(Pt 1): 297-9, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15667331

RESUMEN

Mutational activation of the ras gene is critical for the onset of different malignant phenotypes. We constructed a dominant negative mutant (GEF-DN) of a Ras activator protein (guanine nucleotide-exchange factor) that upon over-expression in k-ras transformed NIH 3T3 fibroblasts strongly reduces intracellular Ras*GTP, reverting these cells to wild-type phenotype for morphology, anchorage-independent growth and reduction of tumour formation in nude mice. Here we review evidence showing that the enhanced proliferation potential of NIH-ras cells requires high initial glucose concentration in the medium and sustained Ras pathway activation. The exquisite sensitivity of NIH-ras fibroblasts to a shortage in nutrient and energy supply highlights an acquired fragility of cancer cells that may be exploited for therapeutic purposes.


Asunto(s)
Fibroblastos/metabolismo , Genes ras , Glucosa/metabolismo , Animales , Línea Celular Transformada , Ratones , Transducción de Señal
5.
Minerva Med ; 81(3 Suppl): 69-72, 1990 Mar.
Artículo en Italiano | MEDLINE | ID: mdl-2325872

RESUMEN

Relapsing polychondritis is a rare disease of undetermined cause. The most frequently seen symptom is redness and swelling of cartilaginous ear, followed by cartilage inflammation elsewhere in the body and inflammation of special sense organs. This report describes recurrent attacks of relapsing polychondritis in one patient, who responded to low doses of corticosteroid therapy. The great relevance of cutaneous vasculitis in our patient, lead us to suggest that PR may fall in to the spectrum of systemic vasculitis.


Asunto(s)
Policondritis Recurrente/diagnóstico , Anciano , Antiinflamatorios/administración & dosificación , Biopsia , Bronquios/patología , Cartílago Auricular/patología , Humanos , Masculino , Policondritis Recurrente/complicaciones , Policondritis Recurrente/tratamiento farmacológico , Policondritis Recurrente/patología , Pregnenodionas/administración & dosificación , Piel/patología , Tráquea/patología
6.
Minerva Med ; 81(3 Suppl): 49-51, 1990 Mar.
Artículo en Italiano | MEDLINE | ID: mdl-2109279

RESUMEN

We describe a 7-years boy by with a meningococcal sepsis due to Neisseria Meningitidis, with very serious evolution of cutaneous necrosis, initial D.I.C. and heart failure. The clinical picture do not improve with antibiotic therapy (CAF-penicillin), but the association ceftriaxone + tobramycin results in rapid improvement. The cutaneous necrosis, especially evident on gluteus, arms and legs, were treated locally with AgNO3 and penicillin-solution. After 4 weeks of treatment, also this cutaneous involvement improved and now the boy is healthy, without residual signs neither systemic nor cutaneous.


Asunto(s)
Infecciones Meningocócicas/patología , Choque Séptico/patología , Enfermedades Cutáneas Infecciosas/patología , Enfermedad Aguda , Niño , Quimioterapia Combinada , Equimosis/tratamiento farmacológico , Equimosis/patología , Humanos , Masculino , Infecciones Meningocócicas/tratamiento farmacológico , Necrosis/tratamiento farmacológico , Necrosis/patología , Neisseria meningitidis , Púrpura/tratamiento farmacológico , Púrpura/patología , Choque Séptico/tratamiento farmacológico , Piel/patología , Enfermedades Cutáneas Infecciosas/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...